80 results
Page 2 of 4
424B3
huwcq8vfw9bt8 ht
5 Sep 23
Prospectus supplement
4:16pm
F-1
7ruubuogcq6u 71l0nv
25 Aug 23
Registration statement (foreign)
4:15pm
6-K
EX-99.3
nx2 2ajmlm
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.2
sbqusp4uqbav2c7s
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.1
qgy53j1ptmcpy
19 Jul 23
Current report (foreign)
9:08am
424B5
dhpcfb1cvvnlq6 6n3a
18 Jul 23
Prospectus supplement for primary offering
11:59am
6-K
EX-99.1
o2gkx4gmx qn
14 Jul 23
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct
3:45pm
424B5
dotpvejb 39la0
14 Jul 23
Prospectus supplement for primary offering
12:26pm
6-K
EX-99.1
35s n54fophm
12 Jul 23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
9:23am
6-K
EX-99.1
ocid71rect5g
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
EX-99.1
aghv6mr3 mw
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
EX-99.3
hell4il2ei
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.2
ffwmn5
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.1
ik5m gjc6wb9b1d51i8
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
EX-99.1
tr3e8
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
EX-99.2
c8jymj7au1 bk
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
EX-99.1
mh3o1o
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am
6-K
EX-99.1
tmdz52v052f8 yh
4 Oct 22
PainReform Provides PRF-110 Manufacturing Update
10:21am
6-K
EX-99.1
gkdj7tar7wh2t8wnjp
16 Aug 22
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
8:08am
6-K
EX-99.2
d3p79
15 Aug 22
Current report (foreign)
6:16pm